Jim C. Williams
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jim C. Williams.
The New England Journal of Medicine | 1988
Joanne M. Langley; Thomas J. Marrie; A. Covert; David M. Waag; Jim C. Williams
Q FEVER, a zoonosis caused by the rickettsia Coxiella burnetii, is endemic in many parts of the world. Cattle, sheep, and goats are the primary animal reservoirs of infection.1 Humans become infect...
American Journal of Public Health | 1985
Thomas J. Marrie; J Van Buren; J Fraser; E. V. Haldane; Ruth S. Faulkner; Jim C. Williams; Carol Kwan
We used the indirect microimmunofluorescence test to determine the presence of antibodies in sheep, cattle, goat, cat, and dog sera to phase I and II Coxiella burnetii antigens in Nova Scotia. Only 6.7 per cent of the 329 sheep tested had antibodies to phase II antigen and none had antibodies to phase I. Of 29 goats tested, 7 per cent and 3.5 per cent had antibodies to phase II and phase I antigens, respectively. In contrast, 23.8 per cent of the 214 cattle tested had antibodies to phase II antigen, and 24.2 per cent had antibodies to phase I antigen; 24.1 per cent of 216 cats tested had antibodies to phase II antigen and 6 per cent had antibodies to phase I antigen. None of the 447 dogs tested had antibodies detected. We conclude that cattle and cats may be reservoirs for human Q fever in Nova Scotia.
Current Microbiology | 1980
Emilio Weiss; Marius G. Peacock; Jim C. Williams
Two serotype 1 strains ofLegionella pneumophila, Phildelphia 2 and Bellingham, were tested for their ability to metabolize five common substrates by measuring14CO2 released and14C-carbon incorporated into macromolecules. No major differences were noted between the two strains or preparations grown in the yolk sac of chick embryos or agar-broth diphasic medium, following 2 or 14 pasaages on agar. Glutamate was the most actively metabolized substrate, followed by glutamine. Acetate, glucose, and succinate were utilized at much more moderate rates. Changes in cell density and substrate concentration altered the channeling of glutamate and glucose into CO2 and macromolecules. Specific CO2 felease from glutamate was greatest at low cell density and high substrate concentration, while carbon incorporation was increased at high substrate concentration. A reciprocal relationship was noted with glucose: the proportion of carbon incorporation was enhanced at low substrate concentration, but CO2 release paralleled increases in substrate concentration. The pH optimum for glutamate carbon incorporation and CO2 release was 5.5 and 6.1, respectively, but 25% of both activities were retained at pH 3.1. CO2 release from glucose was maximal at pH 7.5 with negligible activity at pH 3.1. Pathways of glucose metabolism were explored by employing glucose, glucose-1-phosphate, and glucose-6-phosphate labeled in various carbon positions. The glycolytic pathway appeared to play a lesser role than the pentose phosphate and/or Entner-Doudoroff pathways. Glucose-1-phosphate was metabolized at a much higher rate than glucose or glucose-6-phosphate. We conclude that glutamate is utilized primarily as an energy source while glucose may serve as an important metabolite for the nutrition ofL. pneumophila.
Microbiology | 1990
Shu-Yin Chen; Michael H. Vodkin; Herbert A. Thompson; Jim C. Williams
Two populations of Coxiella burnetii were isolated from fibroblast tissue cultures and examined for their ability to synthesize DNA when incubated in a defined medium. Both the populations released by mechanical lysis of heavily infected host cells, as well as those recovered from the tissue culture medium, incorporated H3 32PO4 into DNA. Incorporation occurred at pH 4.5 but not at pH 7.0, and proceeded for 12-15 h. When incorporation of [3H]thymidine was studied, only the organisms obtained by mechanical lysis of host cells were active. Those which had been released by natural means into the tissue culture medium, and then recovered for study, did not incorporate precursor thymidine but were extremely active in protein biosynthesis. In mechanically released organisms, thymidine incorporation was inhibited immediately by rifamycin (40 microM) and hydroxyurea (10 mM), but it was not affected by chloramphenicol (310 microM) until 4 h after addition of the drug. Incorporation of H3 32PO4 by both populations of organisms was also inhibited by rifamycin, chloramphenicol and hydroxyurea, but the time sequence of inhibition differed. Southern hybridization utilizing 32P-labelled DNA suggested that both populations synthesized authentic chromosomal DNA sequences, as well as QpH1 plasmid DNA, during acid activation of metabolism.
Clinical and Vaccine Immunology | 2008
David M. Waag; Marilyn J. England; Christopher R. Bolt; Jim C. Williams
ABSTRACT Although the phase I Coxiella burnetii cellular vaccine is completely efficacious in humans, adverse local and systemic reactions may develop if immune individuals are inadvertently vaccinated. The phase I chloroform-methanol residue (CMRI) vaccine was developed as a potentially safer alternative. Human volunteers with no evidence of previous exposure to C. burnetii received a subcutaneous vaccination with the CMRI vaccine in phase I studies under protocol IND 3516 to evaluate the safety and immunogenicity of the vaccine. This clinical trial tested escalating doses of the CMRI vaccine, ranging from 0.3 to 60 μg, followed by a booster dose of 30 μg, in a placebo-controlled study. Although priming doses of the CMRI vaccine did not induce a specific antibody detectable by enzyme-linked immunosorbent assay, booster vaccination stimulated the production of significant levels of anti-C. burnetii antibody. Peripheral blood cells (PBCs) of vaccinees responded to C. burnetii cellular antigen in vitro in a vaccine dose-dependent manner. After the booster dose, PBCs were activated by recall antigen in vitro, regardless of the priming dose. These findings suggest that vaccination with the CMRI vaccine can effectively prime the immune system to mount significant anamnestic responses after infection.
Immunopharmacology and Immunotoxicology | 1988
David M. Waag; Jim C. Williams
Coxiella burnetii, the etiological agent of Q fever, possesses immunomodulatory activity which positively and negatively regulates host immune responses. We wish to determine the Coxiella strain differences and the chemical nature of cellular components suppressing lymphocyte responsiveness. The bacterial components responsible for the immunomodulatory activity are associated with phase I cells. In its natural state, the phase I cell-associated, immunosuppressive complex (ISC) was resistant to chemical and enzymatic treatment. The ISC was inactivated and rendered accessible by chloroform-methanol (CM) (4:1) extraction of phase I cells which produced a CM residue (CMRI) and CM extract (CME). The suppressive components in either CMRI or CME did not induce ISC activity in the host when injected separately. Reconstitution of the CMRI with CME prior to injection produced the same pathological reactions characteristic of phase I cells. The CMRI suppressive component was sensitive to alkali, acid, periodate, lysozyme, and neuraminidase, but resistant to lipase and protease. An active component of CMRI was attached to the cell matrix by disulphide bonds. The amphipathic, lipophilic, CME suppressive component was ubiquitously distributed in procaryotes and eukaryotes because ISC activity of CMRI was regained after association with reagent-grade lipids and different CMEs. The ISC was expressed by phase I strains with smooth lipopolysaccharide (LPS) but not by phase II strains with rough LPS. Phase I heart valve strains carrying significant amounts of rough LPS did not express all of the biological properties of the ISC. The LPS molecule induced immune enhancement without immunosuppression. Thus, expression of the ISC showed strain variation and may be under genetic control. The complete details of the chemical composition and active components of the ISC should prove useful for biological-response-modification studies.
The Journal of Infectious Diseases | 1988
Thomas J. Marrie; Heather Durant; Jim C. Williams; Eric D. Mintz; David M. Waag
Journal of Bacteriology | 1992
T A Hoover; M H Vodkin; Jim C. Williams
Archive | 1991
Jim C. Williams; Herbert A. Thompson
Clinical and Vaccine Immunology | 1995
David M. Waag; Kelly T. McKee; Gunnar Sandström; Laura L. K. Pratt; Christopher R. Bolt; Marilyn J. England; Gene O. Nelson; Jim C. Williams
Collaboration
Dive into the Jim C. Williams's collaboration.
United States Army Medical Research Institute of Infectious Diseases
View shared research outputsUnited States Army Medical Research Institute of Infectious Diseases
View shared research outputsUnited States Army Medical Research Institute of Infectious Diseases
View shared research outputs